Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2002;33:1225-1232
doi: 10.1161/01.STR.0000015624.29071.1F
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Claassen, J.
Right arrow Articles by Mayer, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Claassen, J.
Right arrow Articles by Mayer, S. A.
Related Collections
Right arrow Other Stroke Treatment - Medical
Right arrow Brain Circulation and Metabolism
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage
Right arrow Computerized tomography and Magnetic Resonance Imaging

(Stroke. 2002;33:1225.)
© 2002 American Heart Association, Inc.


Original Contributions

Global Cerebral Edema After Subarachnoid Hemorrhage

Frequency, Predictors, and Impact on Outcome

Jan Claassen, MD; J. Ricardo Carhuapoma, MD; Kurt T. Kreiter, MA; Evelyn Y. Du, PhD; E. Sander Connolly, MD Stephan A. Mayer, MD

From the Division of Critical Care Neurology, Department of Neurology (J.C., J.R.C., K.T.K., S.A.M.), the Division of Biostatistics, School of Public Health (E.Y.D.), and the Department of Neurosurgery (E.S.C., S.A.M.), Columbia University College of Physicians and Surgeons, New York, NY.

Reprint requests to Stephan A. Mayer, MD, Division of Critical Care Neurology, Neurological Institute, 710 West 168th St, Unit 39, New York, NY 10032. E-mail sam14{at}columbia.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowSubjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background and Purpose Cerebral edema visualized by CT is often seen after subarachnoid hemorrhage (SAH). Inflammatory or circulatory mechanisms have been postulated to explain this radiographic observation after SAH. We sought to determine the frequency, causes, and impact on outcome of early and delayed global cerebral edema after SAH.

Methods We evaluated the presence of global edema on admission and follow-up CT scans in 374 SAH patients admitted within 5 days of onset to our Neurological Intensive Care Unit between July 1996 and February 2001. Using multivariate analysis, we identified predictors of global cerebral edema and evaluated the impact of global edema on outcome 3 months after onset with the modified Rankin Scale.

Results Global edema was present on admission CT scans in 8% (n=29) and developed secondarily in 12% (n=44) of the patients. Global edema on admission was predicted by loss of consciousness at ictus and increasing Hunt-Hess grade. Delayed global edema was predicted by aneurysm size >10 mm, loss of consciousness at ictus, use of vasopressors, and increased SAH sum scores. Thirty-seven percent (n=137) of the patients were dead or severely disabled (modified Rankin Scale 4 to 6) at 3 months. Death or severe disability was predicted by any global edema, aneurysm size >10 mm, loss of consciousness at ictus, increased National Institutes of Health Stroke Scale scores, and older age.

Conclusions Global edema is an independent risk factor for mortality and poor outcome after SAH. Loss of consciousness, which may reflect ictal cerebral circulatory arrest, is a risk factor for admission global edema, and vasopressor-induced hypertension is associated with the development of delayed global edema. Critical care management strategies that minimize edema formation after SAH may improve outcome.


Key Words: brain edema • cerebral aneurysm • mortality • outcome • subarachnoid hemorrhage


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowSubjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Subarachnoid hemorrhage (SAH) continues to have a substantial impact on mortality1 and has long-lasting effects on the functional status and quality of life of patients who survive.13 Poor neurological status within 24 hours after the ictus,1,4,5 advanced age,1,4,6 and large aneurysm size7 have been consistently identified as predictors of mortality and poor functional outcome after SAH. The presence of intraventricular hemorrhage (IVH), intracerebral hemorrhage (ICH), and extensive subarachnoid blood after SAH on CT are recognized radiological factors considered predictive of poor neurological outcome and mortality.4,5

The presence of cerebral edema, however, has received little attention as a prognostic variable after SAH. This may be due to the fact that global edema is difficult to appreciate and quantify on CT scans. Global edema after SAH may reflect diffuse ischemic injury due to transient ictal cerebral circulatory arrest, diffuse inflammatory or neurotoxic effects of blood and its degradation products on brain tissue, or abnormal autoregulation due to microvascular damage or dysfunction of vasomotor centers in the brain stem. Global edema was seen in 211 (6%) of 3451 admission CT scans in SAH patients in the International Cooperative Study on the Timing of Aneurysm Surgery4 but was not identified as a predictor of mortality. In a previous study, we found that global edema had a strong negative impact on cognitive functioning after SAH.8 To our knowledge, no prior study has focused on cerebral edema as a determinant of outcome after SAH. We sought to determine the frequency, causes, and impact on outcome of early and delayed global cerebral edema after SAH.


*    Subjects and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Subjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Subjects
All SAH patients admitted to the Neurological Intensive Care Unit of Columbia-Presbyterian Medical Center between July 1996 and February 2001 were offered enrollment in the Columbia University SAH Outcomes Project. The study was approved by the hospital’s Institutional Review Board, and in all cases, written informed consent was obtained from the patient or a surrogate. The diagnosis of SAH was established by the admission CT scan or by xanthochromia of the cerebrospinal fluid if the CT was not diagnostic. Patients with aneurysmal and spontaneous nonaneurysmal SAH were included; patients with SAH due to trauma, arteriovenous malformation rupture, vasculitis, and other structural lesions were excluded. Only patients meeting the following criteria were included in the present analysis: (1) admission CT imaging available within 5 days of hemorrhage onset and (2) outcome assessment performed at discharge.

Clinical Management
External ventricular drainage was placed in all patients with symptomatic hydrocephalus or IVH with a reduced level of consciousness. All patients were followed with daily or every-other-day transcranial Doppler (TCD) sonography and received oral nimodipine. To maintain central venous pressure >8 mm Hg, patients were treated with 0.9% normal saline and supplemental 5% albumin solution. Vasopressors were given to patients after surgery to maintain systolic blood pressure in the high normal range (140 to 160 mm Hg). Clinical deterioration from delayed cerebral ischemia was treated with hypertensive hypervolemic therapy (HHT) to maintain systolic blood pressure >200 mm Hg. When clinical evidence of delayed cerebral ischemia persisted despite HHT, balloon angioplasty was performed whenever feasible.

Clinical Variables
We recorded baseline demographic data (age, sex, and ethnicity), social history (tobacco and alcohol use), past medical history (cardiovascular and neurological disease and sentinel bleeding), and clinical features at onset (loss of consciousness or seizures at ictus). A study neurologist performed a neurological and general medical evaluation on admission. Neurological status on admission was assessed with the Glasgow Coma Scale,9 the Hunt-Hess scale,10 the World Federation of Neurosurgeons Scale,11 and the National Institutes of Health Stroke Scale (NIHSS).12 We also assessed the Acute Physiology and Chronic Health Evaluation-2 (APACHE-2) scale13 and calculated a physiological subscore by subtracting the Glasgow Coma Scale, age, and chronic health elements from the total score. We recorded whether patients were hyponatremic (<130 mmol/L) on admission or at any time during hospitalization and documented mean arterial pressure on admission. We identified patients with delayed clinical deterioration or infarction potentially attributable to vasospasm after rigorously excluding other possible causes.14 We also recorded angiographic and TCD findings, mode of aneurysm treatment (clipping versus coiling), whether any vasopressors were used after surgery, and whether vasopressors were used specifically to treat symptomatic vasospasm (HHT).

Radiographic Variables
Admission and follow-up CT scans were independently evaluated by a study neurologist for the presence of focal or global cerebral edema, the amount and location of blood,15 the presence and degree of hydrocephalus,16 and the presence of cerebral infarction. We recorded location and size of the aneurysm and the presence and extent of vasospasm on admission and follow-up angiography. Global cerebral edema was diagnosed when both of the following were present: (1) complete or near-complete effacement of the hemispheric sulci and basal cisterns and (2) bilateral and extensive disruption of the hemispheric gray-white matter junction at the level of the centrum semiovale, which was due to either blurring or diffuse peripheral "fingerlike" extension of the normal demarcation between gray and white matter. Patients were classified as having global edema on the admission CT scan (admission global edema), on >=1 follow-up CT scan (delayed global edema), and on any CT scan (any global edema). Focal cerebral edema was diagnosed when localized brain tissue hypodensities associated with mass effect were present. Focal edema was categorized as (1) hemorrhage-related if the hypodense area surrounded a thick clot in the subarachnoid space or an intraparenchymal hematoma, (2) infarction-related, or (3) related to other causes. When diagnosing edema, infarction, or other radiographic findings, independent confirmation was obtained from the other study physicians. In a prior study, we have shown good to excellent interobserver reliability for SAH (Kw 0.61), IVH (Kw 0.83), and ICH (Kw 0.83) variables in our study population.14 In the present study, we assessed interobserver reliability for global and focal edema by comparing the ratings of 2 independent blinded examiners, each of whom evaluated 36 CT scans selected from our database to provide broad representation as follows: no edema, n=13; global edema, n=10; focal edema, n=7; and global plus focal edema, n=6.

Outcome Variables
Survival and functional outcomes at discharge and at 3 months were assessed with the modified Rankin Scale (mRS). For patients who died in the hospital, we documented the mode of death (cardiac versus brain death) and whether life support was withdrawn in a patient with do-not-resuscitate status according to the patient’s previously stated wishes. A principal cause of death was determined by the treating study neurologist who identified the predominant process leading to cardiac or brain death or devastating neurological injury followed by withdrawal of life support according to the following classification scheme: direct effects of the hemorrhage, aneurysmal rebleeding, medical complications (ie, sepsis or pulmonary embolism), cerebral infarction, herniation from hydrocephalus, herniation from global cerebral edema, and other. The principal cause of death was retrospectively confirmed in each case in a clinical review conducted by 2 additional study physicians. For the analysis of predictors of the 3-month outcome, death or severe disability was defined as an mRS of 4 to 6.

Statistical Analysis
Data analyses were performed with commercially available statistical software (SPSS, version 9.0, SPSS Inc). Kappa scores ({kappa} values) were calculated to assess interobserver reliability for focal and global edema. Univariate associations between candidate predictor variables and global edema and mortality were tested with binary logistic regression analyses. To assess the validity of this approach, we performed a confirmatory univariate analysis using {chi}2 or Fisher exact tests for categorical variables, 2-tailed t tests for normally distributed continuous variables, and Mann-Whitney U tests for nonnormally distributed continuous variables. Among similar variables that were highly intercorrelated (ie, clinical scales), only the variable with the highest odds ratio (OR) and smallest P value in the binary logistic regression analysis was used as a candidate variable in the final multivariate model. Independent predictors of admission global edema, delayed global edema, any global edema, death at 3 months, and death or severe disability at 3 months were identified with backward stepwise multiple logistic regression analysis. We explored 2-way interaction terms among all variables with independent predictive value. When significant 2-way interactions were identified, we reanalyzed the predictive value of each factor after stratifying the analysis between the 2 levels of the other factor. Because of the large number of statistical tests performed, significance was judged at P<0.01.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Demographic and Clinical Features
From a consecutive series of 411 patients with nontraumatic SAH enrolled during the 4.5-year study period, 37 were excluded because a CT scan within 5 days of the hemorrhage was not available, leaving 374 patients for analysis. Eighty-three percent (311 of 374) of the admission CT scans were obtained within 24 hours of symptom onset. Mean±SD age at the time of the hemorrhage was 54±15 years (range 16 to 89 years); 69% (257 patients) were women. Hunt-Hess grades were 1 in 26% (n=98), 2 in 16% (n=61), 3 in 30% (n=112), 4 in 16% (n=58), and 5 in 12% (n=45). In 46 (12%) patients, no aneurysm was found on angiography, and in 21 (6%) patients, angiography was not performed because of poor prognosis. Of the 307 (82%) patients with an identified aneurysm, clipping was performed in 236 patients, and embolization with Guglielmi detachable coils was performed in 56 patients.

Radiological Features
Twenty-nine (8%) patients had global cerebral edema, and 27 (7%) had focal cerebral edema (22 were ICH-related, 4 were SAH-related, and 1 was infarct-related) on the admission CT scan (Figures 1 and 2). Delayed global edema developed in 44 (12%) patients and was first diagnosed on follow-up CT scans performed 2 to 16 days (mean 6.3±3.1 days) after the ictus (Figures 3 and 4). CT interobserver reliability was excellent for focal edema ({kappa}value 0.82) and global edema ({kappa} value 0.89).



View larger version (115K):
[in this window]
[in a new window]
 
Figure 1. Global edema on the admission CT scan. All were obtained within 24 hours of onset. Patient 1 was a 42-year-old man admitted with a Hunt-Hess grade I SAH from a left anterior communicating artery aneurysm. Patient 2 was a 54-year-old woman with a Hunt-Hess grade 2 SAH from a right posterior communicating aneurysm; note the trace amount of SAH in the basal cisterns. Patient 3 was a 32-year-old woman with Hunt-Hess grade 1 SAH from a left ophthalmic artery aneurysm. Patient 4 was a 64-year-old woman with a Hunt-Hess grade 4 SAH from a right middle cerebral artery aneurysm, with a large right perisylvian hematoma. All patients show effacement of the hemispheric sulci and disruption of the hemispheric gray-white matter junction that is due to diffuse peripheral fingerlike extension of the normal demarcation between gray and white matter.



View larger version (107K):
[in this window]
[in a new window]
 
Figure 3. Delayed global edema, with interval effacement of convexity sulci and new appearance of fingerlike lucencies extending from the deep white matter in the follow-up scans. Patient 1 was a 40-year-old man admitted with a Hunt-Hess grade 3 SAH from an anterior communicating artery aneurysm. The patient deteriorated clinically to Hunt-Hess grade 5 on SAH day 1. A follow-up CT scan revealed a global edema pattern that was not present on the admission scan. Patient 2 was a 61-year-old woman admitted with a Hunt-Hess grade 2 SAH from a right anterior communicating aneurysm. On day 4, she developed lethargy with elevated TCD velocities (224 cm/s in the left middle cerebral artery) and was treated with hypertensive-hypervolemic therapy. On day 5, her level of consciousness deteriorated further, and CT scanning showed global edema. She improved clinically after discontinuation of vasopressors. Follow-up CT scans showed gradual resolution of global edema.



View larger version (96K):
[in this window]
[in a new window]
 
Figure 2. Global edema on the admission CT scan (SAH day 0) in a 55-year-old man with a Hunt-Hess grade 5 SAH from a left anterior communicating artery aneurysm that was clipped. A follow-up CT scan on SAH day 18 showed complete normalization of the CT findings. The patient survived with moderate cognitive disability at 3 months.



View larger version (106K):
[in this window]
[in a new window]
 
Figure 4. Delayed global edema related to aneurysm rebleeding. On SAH day 0, this 51-year-old man was admitted with a Hunt-Hess grade 2 SAH from a right anterior cerebral artery aneurysm, without loss of consciousness at ictus. The CT scan (top row) showed diffuse SAH with mild hydrocephalus and no global edema (SAH day 0). The patient experienced rebleeding 12 hours after admission and deteriorated to a coma with extensor posturing. A follow-up CT scan (bottom row) demonstrated massive rebleeding into the anterior interhemispheric fissure and the lateral ventricles, a global edema pattern with effacement of the hemispheric sulci, and disruption of the hemispheric gray-white junction with diffuse peripheral fingerlike lucencies extending from the deep white matter.

Predictors of Admission Global Edema
Six clinical and radiographic variables were associated with global edema on the admission CT scan in the univariate analysis (Table 1). Backward stepwise logistic regression identified loss of consciousness at ictus (OR 3.9, 95% CI 1.0 to 14.9) and a high Hunt-Hess grade (OR 2.3, 95% CI 1.4 to 6.8) as independent predictors of admission global edema (P<0.0001 for the entire model). No interactions were found between these predictors.


View this table:
[in this window]
[in a new window]
 
Table 1. Factors Associated With Global Cerebral Edema

Predictors of Delayed Global Edema
Five clinical and radiographic variables were associated with the development of delayed global edema in the univariate analysis (Table 1). Backward stepwise logistic regression identified aneurysm size >10 mm (OR 5.3, 95% CI 2.3 to 12.2), loss of consciousness at ictus (OR 2.7, 95% CI 1.2 to 6.2), the use of vasopressors (OR 2.4, 95% CI 1.0 to 5.7), and SAH sum score (OR 1.1, 95% CI 1.0 to 1.1) as independent predictors of delayed global edema (P<0.0001 for the entire model). No interactions were found between these predictors.

Predictors of Any Global Edema
Nine clinical and radiographic variables were associated with admission or delayed global edema in the univariate analysis (Table 1). Backward stepwise logistic regression identified aneurysm size >10 mm (OR 3.3, 95% CI 1.5 to 7.0), loss of consciousness at ictus (OR 2.9, 95% CI 1.4 to 6.3), the use of vasopressors (OR 2.2, 95% CI 1.1 to 4.6), and Hunt-Hess score (OR 1.8, 95% CI 1.3 to 2.4) as independent predictors for the development of any global edema (P<0.0001 for the entire model). No interactions were found between these predictors.

Three-Month Outcome
Ninety (24%) patients were dead 3 months after SAH. Mortality was >40% in patients with admission or delayed global cerebral edema compared with 18% in those without global edema (Table 2). Three-month mRS scores were available in 350 patients; in 24, the 3-month mRS score was not available, and the mRS score at discharge was carried forward (6 severely disabled patients [mRS 4 or 5], 18 patients not severely disabled [mRS 0 to 3]).


View this table:
[in this window]
[in a new window]
 
Table 2. Mortality and Severe Disability in Patients With SAH

Predictors of Mortality
Sixteen variables were associated with death at 3 months in the univariate analysis (Table 3). Backward stepwise logistic regression identified loss of consciousness at ictus (OR 2.8, 95% CI 1.4 to 5.6), any global edema (OR 2.5, 95% CI 1.1 to 5.6), a poor Hunt-Hess score (OR 2.0, 95% CI 1.4 to 2.8), APACHE-2 physiological subscore (OR 1.2, 95% CI 1.0 to 1.3), and old age (OR 1.1, 95% CI 1.0 to 1.1) as independent predictors of mortality (P<0.0001 for the entire model). No interactions were found between these predictors. Radiographic predictors of mortality related to SAH, IVH, ICH, and hydrocephalus did not remain in the final model. When admission or delayed global edema was substituted for any global edema in the final model, only delayed global edema remained an independent predictor of death (OR 3.7, 95% CI 1.4 to 9.5).


View this table:
[in this window]
[in a new window]
 
Table 3. Predictors of Mortality and of Mortality or Severe Disability 3 mo After SAH

Predictors of Death or Severe Disability
Sixteen variables were associated with death or severe disability at 3 months in the univariate analysis (Table 3). Backward stepwise logistic regression identified any global edema (OR 2.5, 95% CI 1.2 to 5.4), aneurysm size (OR 2.3, 95% CI 1.2 to 4.6), loss of consciousness at ictus (OR 2.3, 95% CI 1.2 to 4.3), a poor NIHSS score (OR 1.2, 95% CI 1.1 to 1.2), and old age (OR 1.1, 95% CI 1.0 to 1.1) as independent predictors of mortality (P<0.0001 for the entire model). There was an interaction between age and any global edema (P=0.02 in the multivariate model). Stratified analysis showed that any global edema was predictive of death or disability in patients below the median age of 58 years (OR 3.1, 95% CI 1.2 to 7.9) but not among older patients (OR 1.1, 95% CI 0.4 to 3.1). When admission or delayed global edema was substituted for any global edema in the final model, only delayed global edema remained an independent predictor of death or severe disability (OR 4.5, 95% CI 1.8 to 11.0).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
up arrowResults
*Discussion
down arrowReferences
 
In the present study, CT evidence of global cerebral edema was an independent predictor of mortality and poor functional outcome after SAH. Admission global edema was present in 8% of our patients, a frequency similar to that reported by the International Cooperative Study on the Timing of Aneurysm Surgery (6% of 3451 SAH patients).4 Global edema on the admission CT scan was predicted by loss of consciousness at ictus and poor Hunt-Hess grade on admission, suggesting that ictal circulatory arrest may play a role in its pathogenesis. Delayed global edema was identified an average of 6 days (range 2 to 16 days) after the onset of the hemorrhage in an additional 12% of our patients. The use of vasopressors, large aneurysm size, loss of consciousness at ictus, and extent of SAH were independent predictors of delayed global edema. Importantly, hydrocephalus, admission blood pressure, hyponatremia, and various measures of vasospasm (angiographic, TCD, and clinical) were not associated with global edema.

A number of different mechanisms may lead to global edema formation after SAH. The observed association between ictal loss of consciousness and early edema suggests that this radiographic finding may reflect tissue or microvascular injury caused by intracranial circulatory arrest. Insufficient cerebral perfusion caused by severe intracranial hypertension immediately after SAH can lead to a state of transient diffuse ischemic encephalopathy.17 This phenomenon is felt to cause the transient loss of consciousness at onset that occurred in 37% of our cohort and has been reported in 44% by others.18 The triad of (1) vasomotor paralysis, (2) increased cerebral blood volume, and (3) elevated intracranial pressure in patients with global brain edema has been identified after SAH17 and traumatic brain injury19 and has been proposed to be a general reflex phenomenon after severe brain injury.17,19 Experimental models indicate that microcirculatory dysfunction after SAH may result from an initial period of global ischemia,20,21 followed by subsequent recovery of cerebral circulation and "rebound" hyperemia in the setting of abnormal autoregulation.20 In punctured artery models of experimental SAH, global edema develops 1 to 6 hours after ictus,20,22 confirming that this type of edema can develop very early after the insult.

Delayed global cerebral edema after SAH may be related to the following: (1) progression of abnormalities related to ictal circulatory arrest, (2) diffuse microvascular spasm resulting in ischemia, (3) autoregulatory breakthrough in the setting of hypertension, (4) cerebral inflammation induced by blood products, or (5) shifting of water into the intracellular compartment due to hyponatremia. Our findings suggest that the progression of abnormalities related to ictal arrest and induced hypertension may play a role in the development of delayed global edema after SAH. Loss of consciousness at ictus was associated with delayed as well as admission edema in the univariate analysis, and several of the cases that we classified as delayed global edema had subtle disruption of the gray-white matter junction on admission that did not meet our strict radiographic criteria for global edema. Follow-up scans in these cases showed apparent progression of these abnormalities.

Vasopressors were given to 45% of our study cohort, and their use was associated with the development of delayed or any global edema. Autoregulation is impaired after SAH,2325 and in experimental models, the magnitude of vasogenic cerebral edema can be exacerbated by induced hypertension.26 The potential for induced hypertension to cause global edema after SAH has been described by others as well. In a report of 2 patients, HHT for vasospasm after SAH was associated with clinical deterioration attributed to hypertensive encephalopathy.27 The radiographic findings of sulcal effacement, diffuse peripheral fingerlike extension of the normal demarcation between gray and white matter, and hypodensities in the region of the centrum semiovale resembled the findings of our patients with delayed global edema (Figure 3). 27

Our findings do not support a role for arterial vasospasm in the pathogenesis of global cerebral edema after SAH. No measures of large-vessel spasm, as evidenced by angiography, TCD, or clinical findings, were associated with global edema in the present study (Table 1). However, experimental evidence suggests that a vicious cycle of increasing generalized edema, compression of capillaries, and diffuse ischemia may play a role in the development of brain edema after SAH.28 The relationship between microvascular compromise and global edema after SAH requires further study.

Experimental ICH models suggest that blood components (eg, thrombin) are capable of inducing inflammation and vasogenic edema.29,30 Although this concept may also apply for SAH, this has not yet been demonstrated. Cerebral edema may also be caused by hypo-osmolality and hyponatremia after SAH.31 Although this may have played a role in individual patients, hypo-osmolality was not identified as a risk factor for global edema in the present study.

Global edema was an independent predictor of death and severe disability 3 months after SAH in the present study, even after the influence of other well-established prognostic variables, such as age,1,4,6 aneurysm size,7 and poor neurological grade on admission,1,4,6 was taken into account. Patients with admission global edema, compared with those without, died earlier (at 2 versus 8 days, respectively) and more often as a direct effect of the hemorrhage (93% versus 48%). A preliminary report of the Cooperative Aneurysm Study reported a mortality risk ratio of 1.71 for admission global edema, defined as "mass effect" among a cohort of 1734 SAH patients.32 However, this variable did not remain an independent predictor when evaluated together with level of consciousness, IVH, ICH, and amount of SAH.32

Several limitations of the present study deserve mention. The major weakness is that our analysis was based on a dichotomized qualitative assessment of brain edema. Although global brain edema is notoriously difficult to evaluate on CT scans, we demonstrated good interrater reliability, which may reflect the fact that our radiographic criteria were intended to identify only very severe cases. For further determination of the prognostic importance of brain edema in SAH patients, quantitative measures of brain water content should be pursued. Hospital mortality can be influenced by decisions to withdraw life support in critically ill neurological patients,33 and it is possible that these decisions may have been biased by radiographic findings. However, the frequency of withdrawing life support was similar in patients with and without global edema (Table 2), and survivors with global edema also had worse functional outcome, suggesting that decisions to withdraw support were based on poor prognosis.

Our findings indicate that global brain edema is an important predictor of poor outcome after SAH and that this CT finding is not merely an epiphenomenon of extensive SAH or severe hydrocephalus. Further research is needed to elucidate the pathogenesis of this disorder, apply imaging strategies that can quantify brain water content, and develop intensive care management strategies that can prevent or minimize brain edema after SAH.


*    Acknowledgments
 
This study was supported by a Grant-in-Aid from the American Heart Association to Dr Mayer (No. 9750432N). Dr Carhuapoma is partly supported by a Daland Fellowship for Clinical Research Award from the American Philosophical Society. We thank the Columbia University Neuro-ICU nurses for their overall support of this project.

Received January 10, 2002; revision received February 8, 2002; accepted February 15, 2002.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
up arrowResults
up arrowDiscussion
*References
 

  1. Longstreth WT Jr, Nelson LM, Koepsell TD, van Belle G. Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington. Neurology. 1993; 43: 712–718.[Abstract/Free Full Text]
  2. Hutter BO, Kreitschmann-Andermahr I, Mayfrank L, Rohde V, Spetzger U, Gilsbach JM. Functional outcome after aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl (Wien). 1999; 72: 157–174.[Medline] [Order article via Infotrieve]
  3. Hackett ML, Anderson CS. Health outcomes 1 year after subarachnoid hemorrhage: an international population-based study: the Australian Cooperative Research on Subarachnoid Hemorrhage Study Group. Neurology. 2000; 12;55: 658–662.
  4. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL. The International Cooperative Study on the Timing of Aneurysm Surgery, 1: overall management results. J Neurosurg. 1990; 73: 18–36.[Medline] [Order article via Infotrieve]
  5. Ogden JA, Mee EW, Henning M. A prospective study of impairment of cognition and memory and recovery after subarachnoid hemorrhage. Neurosurgery. 1993; 33: 572–586.[Medline] [Order article via Infotrieve]
  6. Ogilvy CS, Carter BS. A proposed comprehensive grading system to predict outcome for surgical management of intracranial aneurysms. Neurosurgery. 1998; 42: 959–968.[Medline] [Order article via Infotrieve]
  7. Sundt TM Jr, Piepgras DG, Fode NC, Meyer FB. Giant intracranial aneurysms. Clin Neurosurg. 1991; 37: 116–154.[Medline] [Order article via Infotrieve]
  8. Kreiter KT, Copeland D, Bernardini GL, Bates J, Peery S, Claassen J, Connolly ES, Du YE, Stern Y, Mayer SA. Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke. 2002; 33: 200–209.[Abstract/Free Full Text]
  9. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet. 1974; 2: 81–83.[CrossRef][Medline] [Order article via Infotrieve]
  10. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968; 28: 14–20.[Medline] [Order article via Infotrieve]
  11. Drake GD, Hunt WE, Kassell N, Pertuiset B, Sano K, Teasdale G, DeVillers JC. Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg. 1988; 68: 985–986.[Medline] [Order article via Infotrieve]
  12. Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, Rorick M, Moomaw CJ, Walker M. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989; 20: 864–870.[Abstract/Free Full Text]
  13. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13: 818–829.[Medline] [Order article via Infotrieve]
  14. Claassen J, Bernardini GL, Kreiter KT, Bates JE, Du YE, Copeland D, Connolly ES, Mayer SA. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher Scale revisited. Stroke. 2001; 32: 2012–2020.[Abstract/Free Full Text]
  15. Hijdra A, van Gijn J, Nagelkerke NJ, Vermeulen M, van Crevel H. Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke. 1988; 19: 1250–1256.[Abstract/Free Full Text]
  16. van Gijn J, Hijdra A, Wijdicks EF, Vermeulen M, van Crevel H. Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1985; 63: 355–362.[Medline] [Order article via Infotrieve]
  17. Grote E, Hassler W. The critical first minutes after subarachnoid hemorrhage. Neurosurgery. 1988; 22: 654–661.[Medline] [Order article via Infotrieve]
  18. Hop JW, Rinkel GJ, Algra A, van Gijn J. Initial loss of consciousness and risk of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke. 1999; 30: 2268–2271.[Abstract/Free Full Text]
  19. Krasznai L, Grote EH. Acute vasoparalysis after subarachnoid haemorrhage and cerebral trauma: general reflex phenomenon. Neurol Res. 1994; 16: 40–44.[Medline] [Order article via Infotrieve]
  20. Shigeno T, Fritschka E, Brock M, Schramm J, Shigeno S, Cervos-Navarro J. Cerebral edema following experimental subarachnoid hemorrhage. Stroke. 1982; 13: 368–379.[Abstract/Free Full Text]
  21. Kamiya K, Kuyama H, Symon L. An experimental study of the acute stage of subarachnoid hemorrhage. J Neurosurg. 1983; 59: 917–924.[Medline] [Order article via Infotrieve]
  22. Kuyama H, Ladds A, Branston NM, Nitta M, Symon L. An experimental study of acute subarachnoid haemorrhage in baboons: changes in cerebral blood volume, blood flow, electrical activity and water content. J Neurol Neurosurg Psychiatry. 1984; 47: 354–364.[Abstract]
  23. Yundt KD, Grubb RL Jr, Diringer MN, Powers WJ. Autoregulatory vasodilation of parenchymal vessels is impaired during cerebral vasospasm. J Cereb Blood Flow Metab. 1998; 18: 419–424.[CrossRef][Medline] [Order article via Infotrieve]
  24. Dernbach PD, Little JR, Jones SC, Ebrahim ZY. Altered cerebral autoregulation and CO2 reactivity after aneurysmal subarachnoid hemorrhage. Neurosurgery. 1988; 22: 822–826.[Medline] [Order article via Infotrieve]
  25. Voldby B, Enevoldsen EM, Jensen FT. Cerebrovascular reactivity in patients with ruptured intracranial aneurysms. J Neurosurg. 1985; 62: 59–67.[Medline] [Order article via Infotrieve]
  26. Milhorat TH, Johnson WD, Dow-Edwards DL. Relationship between oedema, blood pressure, and blood flow following local brain injury. Neurol Res. 1989; 11: 29–32.[Medline] [Order article via Infotrieve]
  27. Amin-Hanjani S, Schwartz RB, Sathi S, Stieg PE. Hypertensive encephalopathy as a complication of hyperdynamic therapy for vasospasm: report of two cases. Neurosurgery. 1999; 44: 1113–1116.[Medline] [Order article via Infotrieve]
  28. Johshita H, Kassell NF, Sasaki T, Ogawa H. Impaired capillary perfusion and brain edema following experimental subarachnoid hemorrhage: a morphometric study. J Neurosurg. 1990; 73: 410–417.[Medline] [Order article via Infotrieve]
  29. Lee KR, Colon GP, Betz AL, Keep RF, Kim S, Hoff JT. Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg. 1996; 84: 91–96.[Medline] [Order article via Infotrieve]
  30. Xi G, Wagner KR, Keep RF, Hua Y, de Courten-Myers GM, Broderick JP, Brott TG, Hoff JT, Muizelaar JP. Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke. 1998; 29: 2580–2586.[Abstract/Free Full Text]
  31. Zerbe R, Stropes L, Robertson G. Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med. 1980; 31: 315–327.[CrossRef][Medline] [Order article via Infotrieve]
  32. Adams HP Jr, Kassell NF, Torner JC. Usefulness of computed tomography in predicting outcome after aneurysmal subarachnoid hemorrhage: a preliminary report of the Cooperative Aneurysm Study. Neurology. 1985; 35: 1263–1267.[Abstract/Free Full Text]
  33. Mayer SA, Kossoff SB. Withdrawal of life support in the neurological intensive care unit. Neurology. 1999; 52: 1602–1609.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
RadiologyHome page
Y. Liu, V. Soppi, T. Mustonen, M. Kononen, T. Koivisto, A. Koskela, J. Rinne, and R. L. Vanninen
Subarachnoid Hemorrhage in the Subacute Stage: Elevated Apparent Diffusion Coefficient in Normal-appearing Brain Tissue after Treatment
Radiology, December 19, 2006; (2006) 2422051698.
[Abstract] [Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A M Naidech, J Drescher, P Tamul, A Shaibani, H H Batjer, and M J Alberts
Acute physiological derangement is associated with early radiographic cerebral infarction after subarachnoid haemorrhage
J. Neurol. Neurosurg. Psychiatry, December 1, 2006; 77(12): 1340 - 1344.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
J. B. Springborg, H.-J. Frederiksen, V. Eskesen, and N. V. Olsen
Trends in monitoring patients with aneurysmal subarachnoid haemorrhage
Br. J. Anaesth., March 1, 2005; 94(3): 259 - 270.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. M. Naidech, K. T. Kreiter, N. Janjua, N. Ostapkovich, A. Parra, C. Commichau, E. S. Connolly, S. A. Mayer, and B.-F. M. Fitzsimmons
Phenytoin Exposure Is Associated With Functional and Cognitive Disability After Subarachnoid Hemorrhage
Stroke, March 1, 2005; 36(3): 583 - 587.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W.-D. Niesen, M. Rosenkranz, W. Schummer, C. Weiller, and U. Sliwka
Cerebral Venous Flow Velocity Predicts Poor Outcome in Subarachnoid Hemorrhage
Stroke, August 1, 2004; 35(8): 1873 - 1878.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. G. Kowalski, J. Claassen, K. T. Kreiter, J. E. Bates, N. D. Ostapkovich, E. S. Connolly, and S. A. Mayer
Initial Misdiagnosis and Outcome After Subarachnoid Hemorrhage
JAMA, February 18, 2004; 291(7): 866 - 869.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Claassen, S. Peery, K.T. Kreiter, L.J. Hirsch, E.Y. Du, E.S. Connolly, and S.A. Mayer
Predictors and clinical impact of epilepsy after subarachnoid hemorrhage
Neurology, January 28, 2003; 60(2): 208 - 214.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Lagares, P.A. Gomez, J.F. Alen, R.D. Lobato, J. Campollo, J. Claassen, and S. A. Mayer
Global Cerebral Edema After Subarachnoid Hemorrhage * Response
Stroke, September 1, 2002; 33(9): 2153 - 2154.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Claassen, J.
Right arrow Articles by Mayer, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Claassen, J.
Right arrow Articles by Mayer, S. A.
Related Collections
Right arrow Other Stroke Treatment - Medical
Right arrow Brain Circulation and Metabolism
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage
Right arrow Computerized tomography and Magnetic Resonance Imaging